FDA Approves New Treatment for Bacterial Pneumonia

2019-06-06 |

The FDA approved a new indication for the previously approved drug, Zerbaxa (ceftolozane and tazobactam) for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients 18 years and older. Read more.